Among patients with asthma who received four doses of depemokimab over 2 years, the annualized exacerbation rate was low, ...

Une femme enceinte asthmatique doit bénéficier d’une prise en charge thérapeutiCorticosteroids and short-acting beta agonists remain the core therapies for pregnant patients with asthma.

A LOW COST ALTERNATIVE FOR COMMONLY USED ASTHMA MEDICATION WILL ENTER THE MARKET AFTER PRESSURE FROM SENATOR MAGGIE HASSAN ...

After GSK replaced a popular asthma inhaler with an identical product at a higher price, families reported substantial ...

The White House is looking to intensify its pressure campaign on Congress to pass legislation to codify a “most-favored nation” drug pricing policy ...

An asthma medication improves asthma control, respiratory quality of life, and upper airway symptoms in patients with chronic ...

Glaxo Smith Kline’s decision to discontinue a popular children’s asthma inhaler, Flovent, more than two years ago has caused ...

A major pharmaceutical company ended price hikes and monopoly protection over a life-saving asthma inhaler following two years of pressure from U.S. Sen. Maggie Hassan, D-N.H. Without warning in ...

Better insulation and ventilation in social housing mean thousands of children no longer need medication for asthma or ...

"Today's approval of the first generic fluticasone propionate inhalation aerosol represents an important step in expanding access to affordable asthma treatment," said Iilun Murph ...

Upstream Bio (UPB) lost ~12% in the premarket on Wednesday even after the company said that a mid-stage trial for its experimental asthma therapy, verekitug, succeeded, paving the way for the drug's ...

Following last week’s launch of TrumpRx, a federal government-based prescription drug platform, doctors are speaking about its potential benefits for consumers — and also its limitations. The platform ...